This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the effect and safety of atypical antipsychotics compared to placebo in disruptive behavioural disorders in children and youths. The aim is to evaluate each drug separately rather than the class effect. The rationale for this approach is that this is more clinically useful.